3rd Quarter - Report

THE GIBSON GROUP, LLC for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Competition issues in the pharmaceutical benefit manager industry S. 3822 - Break Up Big Medicine Act Monetary penalties in PBM legislation

LobbyistCovered position, as disclosed
JOSEPH H GIBSON Counsel for Legislative & Intergovernmental Affairs Anti Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3822 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.